Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Aside from share price ... smells right for some bolt-ons

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Jan 16, 2023 8:50pm

124 Views

Post# 35226922

RE:RE:RE:RE:RE:RE:Aside from share price ... smells right for some bolt-ons

Not sure what you're saying Snowball - it definately isn't dead capital.
The money was used to acquire and grow revenue from $300K to a quater billion in 7 years.
The first 3 year was mostly about heavy financing and building the Canadian arm.

The capital is far from dead.

Now the share price ... that's been dead ... but I knew that was going to be the case all along.

I don't care about the share price and neither do the majority of the shares. Understand that and accept that - nothing you can do about that.

Focus on what you can do - focus on what you have control over.

Simple !!!!

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario